A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic

被引：3

作者：

Hageman, Thomas M. ^{[1
]}

Palmer, Joshua ^{[2
]}

Mullick, Prabir ^{[3
]}

Lee, Heeyoung ^{[4
]}

机构：

[1] LifeStance Hlth Inc, San Antonio, TX 78229 USA

[2] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA

[3] PK Mullick & Associates Complete Psychiat Care, Pittsburgh, PA USA

[4] Univ Pittsburgh, Sch Nursing, Dept Hlth & Community Syst, Adm, Pittsburgh, PA 15261 USA

来源：

JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 03期

关键词：

buprenorphine; medication assisted treatment; opioid use disorder; telemental health;

D O I：

10.1016/j.nurpra.2021.12.025

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre-COVID-19 vs post onset of COVID-19 data. In the sample of 28 adults, mean attendance rates did not differ significantly before (99.46%) vs during the pandemic (96.13%; t = 1.92, P = .07). Patient participation in therapy before and during the pandemic did differ significantly (chi(2) = 1.98, P = .03). The use of telemental health services within a BMT program may be a viable option when normal in-person services are disrupted. Published by Elsevier Inc.

引用

页码：267 / 271

页数：5

共 50 条

[1] National trends in buprenorphine prescribing before and during the COVID-19 pandemic
Ali, Mir M.
Creedon, Timothy B.
Jacobus-Kantor, Laura
Sherry, Tisamarie B.
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2023, 144
[2] Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program
Harris, Robert
Rosecrans, Amanda
Zoltick, Meredith
Willman, Catherine
Saxton, Ronald
Cotterell, Margaret
Bell, Joy
Blackwell, Ingrid
Page, Kathleen R.
DRUG AND ALCOHOL DEPENDENCE, 2022, 230
[3] Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic
Nordeck, Courtney D.
Buresh, Megan
Krawczyk, Noa
Fingerhood, Michael
Agus, Deborah
JOURNAL OF ADDICTION MEDICINE, 2021, 15 (05) : 364 - 369
[4] Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
Wang, Linda
Weiss, Jeffrey
Ryan, Elizabeth Bogel
Waldman, Justine
Rubin, Stacey
Griffin, Judy L.
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 124
[5] Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States
O'Donoghue, Ashley L.
Reichheld, Alyse
Anderson, Timothy S.
Zera, Chloe A.
Dechen, Tenzin
Stevens, Jennifer P.
JOURNAL OF ADDICTION MEDICINE, 2023, 17 (06) : E399 - E402
[6] A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic
Cunningham, Chinazo O.
Khalid, Laila
Deng, Yuting
Torres-Lockhart, Kristine
Masyukova, Mariya
Thomas, Shenell
Zhang, Chenshu
Lu, Tiffany
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 135
[7] Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic
Duncan, Alexandra
Sanders, Noah
Schiff, Maria
Winkelman, Tyler N. A.
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 121
[8] Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
Chalasani, Rohan
Shinabery, Jared M.
Goetz, Carrie Thomas
Chang, Chung-Chou H.
Yang, Qingnan
Suda, Katie J.
Gellad, Walid F.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (12) : 3915 - 3917
[9] Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky
Lei, Feitong
Lofwall, Michelle R.
Freeman, Patricia R.
Slade, Emily
Vickers-Smith, Rachel
Slavova, Svetla
JOURNAL OF RURAL HEALTH, 2023, 39 (01) : 186 - 196
[10] Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
Arunogiri, Shalini
Lintzeris, Nicholas
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 124

← 1 2 3 4 5 →